Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week

As the new week unfolds, earnings and economic data will again dictate sentiment.

MARA : 21.07 (+1.35%)
BLK : 1,047.37 (+0.03%)
NFLX : 823.96 (-1.59%)
PDD : 114.00 (+1.49%)
AUPH : 8.12 (-2.52%)
CKPT : 3.43 (-9.26%)
EVH : 12.38 (-2.29%)
EBS : 7.72 (-16.72%)
BIDU : 84.58 (+0.62%)
SPY : 585.75 (-1.28%)
COIN : 305.85 (+9.69%)
Emergent Biosolutions Stock Soars After Q3 Earnings: Retail Sentiment Strong

Earnings per share for Q3 came in at $1.37, compared to consensus estimates of $0.10.

IWC : 129.00 (-1.74%)
EBS : 7.72 (-16.72%)
VTI : 290.31 (-1.27%)
XBI : 91.83 (-5.29%)
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript

EBS earnings call for the period ending September 30, 2024.

EBS : 7.72 (-16.72%)
Emergent Biosolutions: Q3 Earnings Snapshot

Emergent Biosolutions: Q3 Earnings Snapshot

EBS : 7.72 (-16.72%)
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

EBS : 7.72 (-16.72%)
Emergent BioSolutions Reports Third Quarter 2024 Financial Results

EBS : 7.72 (-16.72%)
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development

EBS : 7.72 (-16.72%)
5 Broker Liked Stocks to Keep an Eye on After Recent Analyst Upgrades

After performing impressively in September, volatility returned to grip the U.S. equity markets in October. The hotter-than-expected inflation reading for September has reignited recession fears. In September,...

ACDVF : 17.2900 (-0.80%)
CBRL : 48.81 (+1.54%)
EBS : 7.72 (-16.72%)
BRY : 4.28 (-4.25%)
AAL : 14.39 (+0.91%)
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

EBS : 7.72 (-16.72%)
Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata

For Immediate ReleaseChicago, IL – October 15, 2024 – Stocks in this week’s article are Grupo Supervielle S.A. SUPV, Emergent BioSolutions Inc. EBS and Innodata Inc. INOD.3 Stocks Poised for Better...

EBS : 7.72 (-16.72%)
INOD : 36.75 (-6.15%)
SUPV : 10.62 (+2.31%)

Barchart Exclusives

Is This Nuclear Energy Stock a Buy, Sell, or Hold After Earnings?
Nuclear stocks are gaining momentum, and Vistra is leading the charge. With investments in zero-carbon assets and a bullish outlook from analysts, the company is capitalizing on the nuclear sector's resurgence Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar